Neogen Historical Financial Ratios

NEOG Stock

USD 11.64 0.49 4.04%

Neogen is lately reporting on over 108 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Days Sales Outstanding of 53.41 will help investors to properly organize and evaluate Neogen financial condition quickly.

Quick Ratio Current Ratio

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Neogen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.

For more detail on how to invest in Neogen Stock please use our How to Invest in Neogen guide.

About Neogen Financial Ratios Analysis

NeogenFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Neogen investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Neogen financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Neogen history.

Neogen Financial Ratios Chart

At this time, Neogen's Operating Cash Flow Per Share is most likely to increase slightly in the upcoming years. The Neogen's current Capex To Depreciation is estimated to increase to 1.36, while Days Sales Outstanding is projected to decrease to 53.41.

Price To Sales Ratio Days Sales Outstanding Book Value Per Share Operating Cash Flow Per Share Ev To Sales Net Current Asset Value

Add Fundamental

Price To Sales Ratio

Price to Sales Ratio is figured by comparing Neogen stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Neogen sales, a figure that is much harder to manipulate than other Neogen multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Book Value Per Share

The ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of a company according to its financial statements.

Operating Cash Flow Per Share

A measure of the cash generated from a company's normal business operations per share, indicating how much cash is generated from a company's business operations on a per-share basis.

Ev To Sales

The Enterprise Value to Sales ratio, a valuation metric used to compare the value of a company, including debt and excluding cash, to its sales revenue.

Most ratios from Neogen's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Neogen current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Neogen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.

For more detail on how to invest in Neogen Stock please use our How to Invest in Neogen guide.At this time, Neogen's Operating Cash Flow Per Share is most likely to increase slightly in the upcoming years. The Neogen's current Capex To Depreciation is estimated to increase to 1.36, while Days Sales Outstanding is projected to decrease to 53.41.

	2021	2022	2023	2024 (projected)
Inventory Turnover	2.32	3.11	2.43	1.69
ROIC	0.0316	0.009683	0.009581	0.009102

Inventory Turnover Roic

Neogen fundamentals Correlations

	Price To Sales Ratio	Ptb Ratio	Days Sales Outstanding	Book Value Per Share	Free Cash Flow Yield	Operating Cash Flow Per Share	Capex To Depreciation	Pb Ratio	Ev To Sales	Free Cash Flow Per Share	Roic	Inventory Turnover	Net Income Per Share	Days Of Inventory On Hand	Payables Turnover	Capex To Revenue	Cash Per Share	Pocfratio	Interest Coverage	Capex To Operating Cash Flow	Pfcf Ratio	Days Payables Outstanding	Income Quality	Roe	Ev To Operating Cash Flow	Pe Ratio
Price To Sales Ratio		0.88	0.6	-0.21	0.7	0.89	0.26	0.88	0.97	0.84	-0.36	0.45	0.9	-0.52	0.67	-0.38	0.7	0.07	0.53	-0.47	0.58	-0.65	0.59	0.0	-0.14	0.64
Ptb Ratio	0.88		0.77	-0.31	0.89	0.74	0.41	1.0	0.84	0.76	-0.51	0.6	0.86	-0.7	0.79	-0.39	0.48	0.16	0.55	-0.44	0.72	-0.77	0.59	-0.09	-0.08	0.66
Days Sales Outstanding	0.6	0.77		-0.23	0.8	0.52	0.16	0.77	0.61	0.57	-0.5	0.77	0.63	-0.82	0.5	-0.4	0.35	0.19	0.41	-0.38	0.56	-0.43	0.48	-0.17	-0.02	0.55
Book Value Per Share	-0.21	-0.31	-0.23		-0.06	-0.05	-0.17	-0.31	-0.1	-0.49	-0.57	0.1	-0.42	-0.14	-0.57	0.82	0.06	0.78	-0.86	0.83	-0.72	0.62	-0.81	-0.86	0.89	-0.78
Free Cash Flow Yield	0.7	0.89	0.8	-0.06		0.69	0.36	0.89	0.7	0.63	-0.75	0.72	0.72	-0.83	0.64	-0.24	0.49	0.35	0.25	-0.25	0.53	-0.6	0.42	-0.39	0.15	0.5
Operating Cash Flow Per Share	0.89	0.74	0.52	-0.05	0.69		0.1	0.74	0.91	0.88	-0.42	0.35	0.89	-0.44	0.57	-0.32	0.89	0.03	0.28	-0.4	0.43	-0.56	0.53	-0.12	-0.12	0.55
Capex To Depreciation	0.26	0.41	0.16	-0.17	0.36	0.1		0.41	0.18	0.07	-0.31	0.04	0.22	-0.16	0.15	0.21	0.03	0.19	0.21	0.04	0.49	-0.28	0.12	-0.12	0.08	0.16
Pb Ratio	0.88	1.0	0.77	-0.31	0.89	0.74	0.41		0.84	0.76	-0.51	0.6	0.86	-0.7	0.79	-0.39	0.48	0.16	0.55	-0.44	0.72	-0.77	0.59	-0.09	-0.08	0.66
Ev To Sales	0.97	0.84	0.61	-0.1	0.7	0.91	0.18	0.84		0.82	-0.41	0.5	0.87	-0.56	0.56	-0.34	0.78	0.12	0.37	-0.43	0.5	-0.54	0.54	-0.09	-0.07	0.6
Free Cash Flow Per Share	0.84	0.76	0.57	-0.49	0.63	0.88	0.07	0.76	0.82		-0.08	0.32	0.94	-0.35	0.75	-0.73	0.74	-0.36	0.63	-0.78	0.64	-0.74	0.87	0.3	-0.53	0.87
Roic	-0.36	-0.51	-0.5	-0.57	-0.75	-0.42	-0.31	-0.51	-0.41	-0.08		-0.58	-0.25	0.73	-0.14	-0.42	-0.33	-0.84	0.36	-0.43	-0.04	0.1	0.26	0.89	-0.74	0.17
Inventory Turnover	0.45	0.6	0.77	0.1	0.72	0.35	0.04	0.6	0.5	0.32	-0.58		0.32	-0.97	0.27	-0.18	0.14	0.39	0.11	-0.16	0.08	-0.13	0.2	-0.38	0.24	0.28
Net Income Per Share	0.9	0.86	0.63	-0.42	0.72	0.89	0.22	0.86	0.87	0.94	-0.25	0.32		-0.41	0.8	-0.56	0.75	-0.15	0.59	-0.62	0.76	-0.8	0.75	0.16	-0.35	0.78
Days Of Inventory On Hand	-0.52	-0.7	-0.82	-0.14	-0.83	-0.44	-0.16	-0.7	-0.56	-0.35	0.73	-0.97	-0.41		-0.34	0.11	-0.23	-0.49	-0.08	0.09	-0.19	0.22	-0.18	0.49	-0.33	-0.26
Payables Turnover	0.67	0.79	0.5	-0.57	0.64	0.57	0.15	0.79	0.56	0.75	-0.14	0.27	0.8	-0.34		-0.63	0.33	-0.2	0.73	-0.6	0.74	-0.97	0.7	0.26	-0.4	0.72
Capex To Revenue	-0.38	-0.39	-0.4	0.82	-0.24	-0.32	0.21	-0.39	-0.34	-0.73	-0.42	-0.18	-0.56	0.11	-0.63		-0.25	0.72	-0.74	0.97	-0.56	0.6	-0.92	-0.71	0.83	-0.91
Cash Per Share	0.7	0.48	0.35	0.06	0.49	0.89	0.03	0.48	0.78	0.74	-0.33	0.14	0.75	-0.23	0.33	-0.25		0.0	0.06	-0.33	0.33	-0.34	0.44	-0.13	-0.09	0.45
Pocfratio	0.07	0.16	0.19	0.78	0.35	0.03	0.19	0.16	0.12	-0.36	-0.84	0.39	-0.15	-0.49	-0.2	0.72	0.0		-0.55	0.74	-0.26	0.24	-0.64	-0.93	0.96	-0.55
Interest Coverage	0.53	0.55	0.41	-0.86	0.25	0.28	0.21	0.55	0.37	0.63	0.36	0.11	0.59	-0.08	0.73	-0.74	0.06	-0.55		-0.79	0.71	-0.73	0.79	0.7	-0.74	0.79
Capex To Operating Cash Flow	-0.47	-0.44	-0.38	0.83	-0.25	-0.4	0.04	-0.44	-0.43	-0.78	-0.43	-0.16	-0.62	0.09	-0.6	0.97	-0.33	0.74	-0.79		-0.6	0.59	-0.97	-0.74	0.87	-0.95
Pfcf Ratio	0.58	0.72	0.56	-0.72	0.53	0.43	0.49	0.72	0.5	0.64	-0.04	0.08	0.76	-0.19	0.74	-0.56	0.33	-0.26	0.71	-0.6		-0.81	0.73	0.36	-0.46	0.76
Days Payables Outstanding	-0.65	-0.77	-0.43	0.62	-0.6	-0.56	-0.28	-0.77	-0.54	-0.74	0.1	-0.13	-0.8	0.22	-0.97	0.6	-0.34	0.24	-0.73	0.59	-0.81		-0.71	-0.31	0.44	-0.74
Income Quality	0.59	0.59	0.48	-0.81	0.42	0.53	0.12	0.59	0.54	0.87	0.26	0.2	0.75	-0.18	0.7	-0.92	0.44	-0.64	0.79	-0.97	0.73	-0.71		0.62	-0.8	0.99
Roe	0.0	-0.09	-0.17	-0.86	-0.39	-0.12	-0.12	-0.09	-0.09	0.3	0.89	-0.38	0.16	0.49	0.26	-0.71	-0.13	-0.93	0.7	-0.74	0.36	-0.31	0.62		-0.94	0.56
Ev To Operating Cash Flow	-0.14	-0.08	-0.02	0.89	0.15	-0.12	0.08	-0.08	-0.07	-0.53	-0.74	0.24	-0.35	-0.33	-0.4	0.83	-0.09	0.96	-0.74	0.87	-0.46	0.44	-0.8	-0.94		-0.73
Pe Ratio	0.64	0.66	0.55	-0.78	0.5	0.55	0.16	0.66	0.6	0.87	0.17	0.28	0.78	-0.26	0.72	-0.91	0.45	-0.55	0.79	-0.95	0.76	-0.74	0.99	0.56	-0.73

Click cells to compare fundamentals

Neogen Account Relationship Matchups

Neogen fundamentals Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Price To Sales Ratio	9.03	10.37	5.41	4.02	3.08	3.17
Ptb Ratio	5.21	5.78	3.21	1.05	0.91	0.86
Days Sales Outstanding	73.91	71.54	69.01	68.01	68.32	53.41
Book Value Per Share	6.9	7.89	8.24	16.59	14.52	15.25
Free Cash Flow Yield	0.0164	0.0112	0.0153	(0.007486)	(0.0268)	(0.0254)
Operating Cash Flow Per Share	0.62	0.82	0.76	0.63	0.16	0.18
Stock Based Compensation To Revenue	0.0134	0.0155	0.0137	0.0136	0.0124	0.0142
Capex To Depreciation	1.31	1.27	1.03	0.74	0.92	1.36
Pb Ratio	5.21	5.78	3.21	1.05	0.91	0.86
Ev To Sales	8.21	9.56	6.55	4.91	3.88	3.09
Free Cash Flow Per Share	0.59	0.51	0.4	(0.13)	(0.35)	(0.33)
Roic	0.0557	0.0511	0.0316	0.009683	0.009581	0.009102
Inventory Turnover	2.33	2.52	2.32	3.11	2.43	1.69
Days Of Inventory On Hand	156.36	145.05	157.12	117.27	150.07	201.93
Payables Turnover	8.65	10.6	8.21	5.43	5.54	7.55
Sales General And Administrative To Revenue	0.0952	0.0985	0.11	0.16	0.24	0.22
Research And Ddevelopement To Revenue	0.0353	0.0347	0.0323	0.0317	0.0243	0.0231
Capex To Revenue	0.0575	0.057	0.0463	0.08	0.12	0.13
Cash Per Share	5.91	6.45	6.66	1.3	0.79	0.87
Pocfratio	43.96	59.92	41.88	80.52	80.73	84.76
Pfcf Ratio	61.06	89.35	65.34	(133.59)	(37.38)	(35.51)
Days Payables Outstanding	42.19	34.43	44.46	67.19	65.86	46.01
Income Quality	1.44	1.33	1.41	(1.79)	(3.74)	(3.56)
Roe	0.082	0.0724	0.0544	(0.007297)	(0.002996)	(0.002847)
Ev To Operating Cash Flow	39.97	55.23	50.78	98.48	101.59	106.67
Pe Ratio	63.48	79.8	58.98	(144.45)	(302.17)	(287.06)
Return On Tangible Assets	0.0965	0.088	0.0655	(0.0291)	(0.0104)	(0.009927)
Ev To Free Cash Flow	55.52	82.36	79.23	(163.38)	(47.04)	(44.69)
Earnings Yield	0.0158	0.0125	0.017	(0.006923)	(0.003309)	(0.003144)
Net Debt To E B I T D A	(3.99)	(3.86)	5.61	6.02	4.03	4.23
Current Ratio	11.08	11.03	8.05	4.03	3.82	5.47
Tangible Book Value Per Share	5.18	5.75	5.87	(3.36)	(2.32)	(2.21)
Receivables Turnover	4.94	5.1	5.29	5.37	5.34	6.26
Graham Number	9.37	10.07	9.12	6.72	3.77	2.34
Shareholders Equity Per Share	6.9	7.89	8.24	16.59	14.52	15.25

Currently Active Assets on Macroaxis

C	Citigroup
GM	General Motors
F	Ford Motor
GM	General Motors
V	Visa Class A

When determining whether Neogen is a strong investment it is important to analyze Neogen's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Neogen's future performance. For an informed investment choice regarding Neogen Stock, refer to the following important reports:

How To Invest In Neogen

Details

Is Neogen Stock a good investment?

Details

What is Neogen's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

For more detail on how to invest in Neogen Stock please use our How to Invest in Neogen guide.

You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Neogen. If investors know Neogen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Neogen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.86)

Earnings Share

(0.11)

Revenue Per Share

4.212

Quarterly Revenue Growth

(0.05)

Return On Assets

0.0085

The market value of Neogen is measured differently than its book value, which is the value of Neogen that is recorded on the company's balance sheet. Investors also form their own opinion of Neogen's value that differs from its market value or its book value, called intrinsic value, which is Neogen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Neogen's market value can be influenced by many factors that don't directly affect Neogen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Neogen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Neogen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Neogen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Price To Sales Ratio	Dividend Yield
Ptb Ratio	Days Sales Outstanding
Book Value Per Share	Free Cash Flow Yield
Invested Capital	Operating Cash Flow Per Share
Average Payables	Stock Based Compensation To Revenue
Capex To Depreciation	Pb Ratio
Ev To Sales	Free Cash Flow Per Share
Roic	Inventory Turnover
Net Income Per Share	Days Of Inventory On Hand
Payables Turnover	Sales General And Administrative To Revenue
Average Inventory	Research And Ddevelopement To Revenue
Capex To Revenue	Cash Per Share
Pocfratio	Interest Coverage
Payout Ratio	Capex To Operating Cash Flow
Pfcf Ratio	Days Payables Outstanding
Net Current Asset Value	Income Quality
Roe	Tangible Asset Value
Ev To Operating Cash Flow	Pe Ratio
Return On Tangible Assets	Ev To Free Cash Flow
Earnings Yield	Intangibles To Total Assets
Net Debt To E B I T D A	Current Ratio
Tangible Book Value Per Share	Receivables Turnover
Graham Number	Shareholders Equity Per Share
Debt To Equity	Capex Per Share
Graham Net Net	Average Receivables
Revenue Per Share	Interest Debt Per Share
Debt To Assets	Enterprise Value Over E B I T D A
Short Term Coverage Ratios	Price Earnings Ratio
Operating Cycle	Price Book Value Ratio
Price Earnings To Growth Ratio	Days Of Payables Outstanding
Dividend Payout Ratio	Price To Operating Cash Flows Ratio
Price To Free Cash Flows Ratio	Pretax Profit Margin
Ebt Per Ebit	Operating Profit Margin
Effective Tax Rate	Company Equity Multiplier
Long Term Debt To Capitalization	Total Debt To Capitalization
Return On Capital Employed	Debt Equity Ratio
Ebit Per Revenue	Quick Ratio
Dividend Paid And Capex Coverage Ratio	Net Income Per E B T
Cash Ratio	Cash Conversion Cycle
Operating Cash Flow Sales Ratio	Days Of Inventory Outstanding
Days Of Sales Outstanding	Free Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage Ratios	Price To Book Ratio
Fixed Asset Turnover	Capital Expenditure Coverage Ratio
Price Cash Flow Ratio	Enterprise Value Multiple
Debt Ratio	Cash Flow To Debt Ratio
Price Sales Ratio	Return On Assets
Asset Turnover	Net Profit Margin
Gross Profit Margin	Price Fair Value
Return On Equity

Neogen Historical Financial Ratios

About Neogen Financial Ratios Analysis

Neogen Financial Ratios Chart

Price To Sales Ratio

Book Value Per Share

Operating Cash Flow Per Share

Ev To Sales

Neogen fundamentals Correlations

Neogen Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Neogen fundamentals Accounts

Currently Active Assets on Macroaxis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Pb Ratio	+ 1.0	Ptb Ratio
Pe Ratio	+ 0.99	Income Quality
Ev To Sales	+ 0.97	Price To Sales Ratio
Capex To Operating Cash Flow	+ 0.97	Capex To Revenue
Ev To Operating Cash Flow	+ 0.96	Pocfratio
Net Income Per Share	+ 0.94	Free Cash Flow Per Share

Income Quality	- 0.97	Capex To Operating Cash Flow
Days Payables Outstanding	- 0.97	Payables Turnover
Days Of Inventory On Hand	- 0.97	Inventory Turnover
Pe Ratio	- 0.95	Capex To Operating Cash Flow
Ev To Operating Cash Flow	- 0.94	Roe
Roe	- 0.93	Pocfratio